Need help?

800-5315-2751 Hours: 8am-5pm PST M-Th;  8am-4pm PST Fri
Medicine Lakex


Surveillance & Society 1(1): 86-101
Technical Review. Hair Testing: just how accurate

Extensive forensic examination of the hair of 209 "ecstasy" (MDMA) users demonstrated virtually no
correlation between self-reported tablet use, and traces of MDMA in the hair of users. Why should this be
so? Three answers are possible, and all true. First, self-report is fallible; second, tablet strength varies
enormously; and third, forensic analysis is of unknown accuracy. The first two are well known. Forensic
analysis, however, typically presents itself as impeccably precise. The review demonstrates that not only is
this claim spectacularly untrue, but also that validation of forensic analysis (and, thus, indirectly, self-
report) lies in the very blind intra - and inter- laboratory comparisons that are never undertaken.


Although the results of testing hair for the presence of poisons have been accepted - at
least in American courts - for over a century (Mieczkowski, 1996: 61), hair testing for
evidence of the use of drugs has not yet reached that degree of full judicial acceptability
(Huestis, 1996a), although there are various reports of quasi-judicial use (Tagliaro, et al.,
1997; Moeller, 1996; Moeller, et al., 1993; and Lewis, et al., 1997).
Hair testing began slowly about 20 years ago, initiated, perhaps, by Baumgartner's
pioneering article (Baumgartner, et al., 1978). Sachs (1997: 8-9) suggests an erratic
growth thereafter, with a "gold rush" period between 1986 and 1992 typified by relatively
uncritical use of hair testing, followed by a "hang over" period between 1992 and 1996
characterised by more critical reflection. It seems that a renewed "gold rush" - at least of
published papers if not of conclusive results - began thereafter.
Hair allegedly offers one crucial potential advantage when compared to, for example, urine as a medium for divination - the long time window. Whereas urine can only indicate use for 2-3 days for opiates, cocaine and the amphetamines, hair offers the possibility of retrospective use examination for at least 3 months, and possibly as long as 12 months. Indeed, Baumgartner, et al. (1989:1447-8) claim to have tested 5 hairs, 7.6cm 1 Department of Law, University of Sheffield, UK; and Director, Scottish Centre for Criminology, Glasgow, UK. E-mail: 2002 Surveillance & Society and the author(s). All rights reserved. ISSN: 1477-7487 Ditton: Hair Testing in length, from Keats, and, 167 years later, discovered the presence of opiates therein.
Specifically, hair offers the opportunity to examine evidence of drug use for each of the
months separately, rather than merely for all of the months together. A number of other
advantages of hair are sometimes cited (difficult to falsify, easy to store, lengthy shelf
life, low body invasion), but for others, these apparent benefits merely offer more
opportunity to trammel with people's civil liberties for longer periods (Huestis, 1996;
Evans, et al.,1994; Kidwell & Blank, 1996).
Head hair has been examined for the presence of, amongst other substances, heroin
(Baumgartner, et al., 1978; Goldberger, et al., 1991;); cocaine (Baer, et al, 1991;
Baumgartner, 1982; Blank & Kidwell, 1993; Cone, et al., 1991; Garside & Goldberger,
1996; Graham, et al., 1989; Harkey, et al., 1991; Kauert & Röhrich, 1996; Marques, et
, 1993; Marques, 1993; Marques, et al., 1994; Mieczkowski, et al., 1991;
Mieczkowski, 1992; Mieczkowski, 1992a; Mieczkowski & Newell, 1994; Pepin &
Gaillard, 1997;); PCP (Baumgartner, 1981; Nakahara, et al., 1995; Sakamoto & Tanaka,
1996); MDMA (Cirimele, et al., 1995; Kikura, et al., 1997; Kintz & Cirimele, 1997;
Moeller, et al., 1992; Röhrich & Kauert, 1997; Rothe, et al., 1997); cannabis (Cirimele, et
, 1996;); morphine (Cone & Mitchell, 1989; Cone, 1990; Marigo, et al., 1986); codeine
(Cone & Mitchell, 1989;); methamphetamine and/or amphetamine (Ishiyama, et al.,
1983; Kikura, et al., 1994; Kikura & Nakahara, 1995; Ngai, et al., 1989; Nakahara, et al.,
1990; Nakahara, et al., 1991; Nakahara, et al., 1992; Nakahara, et al., 1993; Nakahara,
1995; Nakahara & Kikura, 1996; Nakahara, et al., 1997; Nakahara & Kikura, 1997;
Suzuki, et al., 1984; Suzuki, et al., 1984a; Takayama, et al., 1997); nicotine (Eliopoulos,
et al., 1996; Kintz, et al., 1992;) haloperidol (Matsuno, et al., 1990;) phenobarbitol
(Smith & Pomposine, 1981); and benzodiazepines (Sramek, et al., 1992).
Substances have been detected in beard hair (Nakahara, et al., 1993; Mangin, 1996),
animal hair (Arnold & Puschel, 1981; Harrison, et al., 1974; Kikura & Nakahara, 1995;
Kikura, et al., 1997; Nakahara, 1995; Nakahara & Kikura, 1997), fingernails (Cirimele, et
, 1995), toenails (Suzuki, et al., 1984a), sweat (Hossain & Johnson, 1994) and, on
more than one occasion, in single human head hair strands (Matsuno, et al., 1990; Smith
& Pomposine, 1981; Suzuki, et al., 1984; Takayama, et al., 1997). The latter appears
particularly impressive and perhaps mistakenly gives the impression of microscopic
endeavour coupled to astounding precision.
The Case of "Ecstasy" (MDMA)
Previous work on MDMA (3,4- methylenedioxymethamphetamine) in hair is of some
relevance here for reasons that will become apparent shortly (although Mieczkowski,
1996: 60, considers that MDMA is only incorporated in hair to a "moderate degree"), and
thus deserves a slightly more detailed review. The case reported in Moeller, et al. (1992)
is unhappily almost entirely in Japanese, and interpretation is beyond the current author.
et al. (1995) discovered AP (amphetamine), MDA (3,4- methylenedioxyamphetamine) and MDMA in both the fingernails and head hair of a 22 year old male "known to be a drug user" (68). Kikura and colleagues analysed hair Surveillance & Society 1(1) Ditton: Hair Testing samples from 3 rats that had been given MDMA (amongst other drugs) and also analysed head hair from 7 human "MDMA abusers", in whose hair, MDMA was indeed discovered (Kikura, et al., 1997). Kintz & Cirimele (1997) report a methodological trial involving interlaboratory comparisons of the analysis of a hair sample containing MDMA, MDA and AP, and the laboratory comparison will be discussed in a later section of this paper. At this point, it is merely worth noting that the sample came from "a male subject, aged 24 years, known to be a stimulant abuser and deceased from fatal methylenedioxymethamphetamine overdose" (152). Röhrich & Kauert (1997) spiked drug- free hair samples with MDA, MDMA and MDEA (3,4-methylenedioxyethylamphetamine) for calibration purposes, and subsequently tested "authe ntic hair samples from [303] individuals with suspected drug abuse" (180). They discovered that "28 of these samples (9.3%) contained amphetamine and/or methylenedioxy-amphetamine-derivatives" (187). AP was detected in 23 samples, MDMA in 9, MDA in 6 and MDEA in 5. They conclude (ibid.) "Considering the increasing use of amphetamine and particularly of 'Ecstasy', this number of 28 amphetamine-positive samples seems remarkably low." Finally, Rothe, et al., (1997) examined (proximate 3 cm length) hair sample s from "20 regular 'speed' or 'ecstasy' users of the techno scene.who anonymously reported their drug history in a drugs advice centre." Inevitably, while these "abusers" could report the number of tablets consumed, they could not comment on their relative purity (another issue to be taken up later). The 20 were classified as follows: 7 "insignificant abusers" (up to 1 tablet per month); 5 "moderate abusers" (1-3 tablets per month); 3 "strong abusers" (3-8 tablets per month); and 5 "very strong abusers" (over 8 tablets per month). The mean discovered ng/mg (nanograms per microgram) levels matched their rank order by tablets consumed, although there was considerable variation within each group. For example, in the very strong abuser group, one subject delivered no ng/mg positivity, whereas another delivered over 16 ng/mg. Their ability to discover measurable concentrations of MDMA in the hair of subjects who had consumed less than 1 tablet per month persuades the authors of the sensitivity of hair ana lysis; indeed, they suggest "in cases of ecstasy abuse the intake of 1 tablet may lead to a hair concentration in the order of 1 ng/mg" (126). However, they recognise considerable interindividual variation; and, separately, that participation in the "techno or rave " scene, and associated sweating, can lead to false positives through deposition, and chronological misinterpretation from sweat-assisted migration along the hair shaft. I have summarised these studies at some length as they provide a background to some hair testing of "ecstasy" users that I conducted with colleagues in the mid 1990s, and which is reported at length in Cooper et al. (2000) and Ditton et al. (2000). The aim of that study was to compare self reported "ecstasy" use with the results of the ana lysis of hair harvested from the same users. Subjects were recruited by multi-site chain-referral sampling within the 1994-95 "dance scene" in Glasgow. One hundred subjects donated hair after completing a lengthy interviewer-administered questionnaire. Overall gross Surveillance & Society 1(1) Ditton: Hair Testing concordance between self reported "ecstasy" use, and discovery of MDMA (or related
compounds) in analysed hair did not surpass 59 per cent, and no relationship had a
Cohen's Kappa of more than 0.08. Within the positive concordant data set (n=52), scatter
was considerable, with no correlation being significant, and none more strongly positive
than -0.0518. These results indicate that, as far as MDMA is concerned, if judged by self-
report, hair does not reach a level of apparent accuracy that would permit its use as a
general population estimator.
Why should this be so? There are three main possible problems, and some or all of them
may have led to the low concordance between self-report and forensic examination. They
are: fallibility of self- report, variation in tablet strength, and inaccuracy of forensic
These "ecstasy" users were volunteers, who were given credible guarantees of anonymity
and confidentiality, and who had no obvious motive for exaggerating or minimizing their
prior drug use. Nevertheless, experimentation has shown both that over reporting is more
common than underreporting (Fendrich, et al., 1997) and vice versa (Wish, et al., 1997).
This is sometimes explained by reference to bravado and/or reticence, although it may be
more appropriate instead to consider what experimental and other evidence exists related
to the capability of memory even for those with no wish to report levels of drug use
higher or lower than those actually experienced.
There is an extensive literature on memory problems, and this has been exquisitely
reviewed – recently and with reference to drugs research – by Hammersley (1994). There
is no space to summarise his (for believers in self report) gloomy review here, but it is
difficult to maintain unalloyed faith in the procedure after reading it.
Nevertheless, complete disregard of self report (the stance adopted, inter alia, by
Marques, et al., 1993: 172, who comment: "the widespread use of self report data to
validate technical measures of drug exposure is roughly analogous to having a patient self
report temperature in order to validate a thermometer reading") probably goes too far.
Tablet strength
Independently of these problems of truthful recall and memory difficulty, are problems of
substance purity (although the latter are only rarely referred to in the literature on hair
analysis). Street purchased MDMA is believed to vary significantly in terms of the
proportions of MDMA and other inert components or psychoactive adulterants. Indeed,
as part of the general research design of which hair analysis was a component, the
research team obtained 15 substances bought as "ecstasy", and these were analysed (as
were the hair samples) at Glasgow University's Department of Forensic Medicine and
Science. MDMA content ranged from a "trace", to a high of 70 per cent (with a mean of
34 per cent).
Surveillance & Society 1(1) Ditton: Hair Testing Forensic analysis Turning now to problems associated with forensic analysis, perhaps the main one is an unswerving belief in the validity of clinically generated data, which, when produced by GC/MS (Gas Chromatography / Mass Spectrometry), is often "assumed to be virtually 100 percent accurate" (Harrison & Hughes, 1997: 20). However, forensic analysis of hair for the presence of drugs is not without its own problems. What follows is a digest of recognised problems. Issues relating to laboratory error and/or laboratory contamination of assayed samples are never addressed. First, there are problems of comparison. Hair preparation procedures adopted prior to testing itself vary widely, and new ones are developed with a regularity unjustified by citation of conclusive evidence of superiority. Subsequent forensic tests selected are from a variety of different options which are known to vary in their ability to detect the presence of various substances. Further, cut-off points, which crucially determine the ratio of false positives to false negatives, are not always reported, and when they are, not always similar. Next, there are occasionally problems of credibility. It may not have escaped attention that, of the five English language reports of forensic testing for MDMA use, one analysed hair from somebody "known to be a drug user", a second analysed hair posted from overseas where it had been harvested from "MDMA abusers", and a third analysed a sample from somebody "known to be a stimulant abuser". Only the samples used by Röhrich & Kauert (1997) and Rothe, et al., (1997) come anywhere near sizes or sampling techniques that would permit any acceptable generalisations. Finally, there exist a group of problems which are known to exist, but for which precise parameters have yet to be calibrated. First, rates of hair growth. A norm currently is to assume a growth rate of 1 cm/month (the assumption on which the technical analysis in this paper was based). Not so long ago, however, the American assumption was half an inch/month. Twelve cm is the equivalent of four and three-quarter inches. On the current assumption, this would indicate 12 months of hair growth: on the earlier one, nine and a half months. In addition, rates of hair growth are believed to vary individually from, by one estimate, from 0.6-3.36 cm/month (Harkey, 1993). For an individual at the low end of this scale, 12 cm of hair would reflect 20 months of hair growth; for one at the high end, 12 cm of hair would imply just over three and a half months of hair growth. This is a major, yet typically unaddressed problem. These latter are only averages: the situation for individuals is more complex as hair growth varies by the length of the individual's hair (with "in general, the longer the hair is, the longer the growing phase is ", Harkey & Henderson, 1989: 306); by race (Caucasian hair grows faster than Asian hair); by sex (scalp hair in women grows faster than in men); age (hair growth generally decreases with age); by position on the scalp (hair grows faster in the vertex region than elsewhere); by general location (compared to scalp hair, pubic hair grows more slowly, and beard hair more slowly still); by hair colour (darker hair is more likely to reveal substances or their metabolites); and possibly by hair Surveillance & Society 1(1) Ditton: Hair Testing texture (whether "coarse" or "fine"). In addition, a certain proportion of head hair - usually estimated at 15 per cent of it - is dormant at any one time, and could not, thus, be any sort of calendrical record of consumption. Second, perhaps surprisingly, "hair is a very complex part of the anatomy whose biology is only partially understood" (Harkey, 1993: 9). This leads to two more problems. First, rates of incorporation of substances into hair are believed to vary by many of the dimensions that affect rates of hair growth as noted above. Kidwell & Blank (1996: 39) suggest that cocaine incorporation ratios for Africans:Whites are 2.9:1, and for Koreans:Whites, 6.8:1. Second, here is the more immediately relevant difficulty: the problem of the possibility of external contamination of hair (Pötsch & Moeller, 1996). Harkey (ibid.: 16) comments: "the hair shaft is exposed directly to sebaceous secretions before it emerges from the skin. Scalp hair is also exposed to sweat secretions as well as contaminants in air, water, or dust." Post-harvesting wash procedures are designed to eliminate traces on the external surface of the hair. The extent to which they do so is clearly related to the thoroughness and frequency of washing, with Baumgartner, et al., (1989: 791) indicating that washing has a variable effect with, in one case, removal of 88 per cent of cocaine from a hair sample, and in another, 41 per cent. It is sometimes believed that tracing drug metabolites (rather than the drugs themselves) in hair is indicative of consumption rather than of contamination, but Kidwell & Blank (1993: 140) offer evidence that metabolites have been traced in street samples. The washing problem is akin to the cut-off problem noted above. Too much washing might lead to too many false negatives: too little, too many false positives. It has been noted, by Blank & Kidwell (1993: 149) that, even after "substantial washing", two cocaine spiked samples still retained 211 ng of cocaine or its metabolites/10mg hair. This is equivalent to amounts found in the hair of those classified as heavy cocaine users. Finally, the degree of external contamination will relate to the mechanism and context of original drug delivery. Drugs which are smoked or chased will, presumably, stand a greater chance of externally contaminating hair than those which are consumed orally or by injection. However, most drugs can be delivered by a variety of different methods, and might be consumed differently by one individual on different occasions. Tablets, such as those of MDMA (which is also available in powdered - as well as capsule and tablet - form, and has been known to be injected) are generally handled by those not wearing surgical gloves, who may thereafter run their hands through their own, or somebody else's, hair. If MDMA is consumed in hot dance venues, which is typical in the UK, then the problem of sweat contamination is presumably greater than it may be in cooler drug consumption environments. On the other hand, handling (and subsequent hair- fondling) has been challenged by Mieczkowski (1996: 62) who refers to his work with undercover narcotics officers "who are chronically exposed to cocaine", but who, even after "several thousand" exposures, have "near- zero levels of contamination [and] are readily differentiated from cocaine users". Surveillance & Society 1(1) Ditton: Hair Testing
The effects of the differential regularity and frequency of individual non-experimental
washing, dyeing, perming and otherwise cosmeticising hair are unknown, but cannot be
dismissed. Jurado, et al., (1997) examined the hair of those with similar drug
consumption histories, and concluded that "in all cases the drug content in hair that had
undergone cosmetic treatment decreased in comparison to untreated hair." (159) They
also conclude that shampooing may not have much effect on drug retention, but that
bleaching, dyeing and streaking all do: albeit with different individual variations. Skopp,
et al., (1997: 47) appear to disagree. Their analysis of bleaching indicates that: "in
general, the drug concentrations in virgin hair were slightly lower compared to
cosmetically treated hair."
In the introduction to this chapter, reference was made to Sachs' (1997) distinction
between a "gold rush" phase for hair analysis, followed by a "hang over" one. One
implication is that, in brief, during the "gold rush" era, hair was believed to possess the
probable potential to be an absolute "dosimeter" for drug consumption, whereby
discovered nanograms of any substance would reliably indicate precise quantities of prior
consumption over periods of up to 12 months. The period of retreat typifying the
subsequent "hang over" era has forced a stocktaking, and a revision of expectations down
to hoping that hair may offer what Baumgartner & Hill (1996: 252) latterly have referred
to as a "chronometrically operating relativistic dosimeter": that is, that levels of reported
use (for example, light, intermediate, heavy) might correlate broadly but not exactly, with
equivalent levels of discovered nanograms.
That even this has not proved possible in the analysis presented above does not necessary
mean a further retreat is called for. Instead, improved research protocols might well be
more appropriate, and it is to this that the Conclusion attends.
Whilst the analysis of the materials presented here offers no obvious source of optimism
for the future of hair analysis in the confirmation of MDMA (or related compound) use,
the failure to generate impressively positive results may well be due to the failure of self
report and/or forensic analysis. How could faith in each be enhanced?
Self report would seem to be more reliable if samples are large, voluntary, and not
derived from criminal justice populations. Self report could be more credible if it were
prospective rather than retrospective, and limited, perhaps, to a three month period. The
issue of the consumption of variously adulterated substances is a difficult one to attend to,
but until sampled users can be permitted to return samples of substances along with their
self reported consumption details, little impact on this key issue will be possible. An
alternative is for the sort of controlled dosage studies that Mieczkowski, et al., (1991) has
called for, although these may be harder to organise.
Surveillance & Society 1(1) Ditton: Hair Testing Forensic analysis would, in principle, be surprisingly easy to check for reliability, and if a high degree can be demonstrated to exist, then the need for research into self report itself declines. There would appear to be room for improvement in forensic analysis, and this would be facilitated if considerably heavier hair samples were harvested in future. This would enable double testing of samples: something which should become the norm rather than merely an ideal. Another part of the problem is the proliferation of different washing procedures, assays, etc., on which, Mieczkowski (1991: 68) comments: There is not yet a universal standard for washing the specimens, conducting the assay or establishing quantitative outcomes which are readily extrapolated to consumption levels. Systematic comparison of hair analysis values will require a standardised assay method, and be greatly facilitated by a standard system of reporting outcomes. The establishment of a single method for each could be the basis of a sound interlaboratory and intralaboratory research programme. This has been tried, in part, but only with small samples of rather dubious authenticity, or with possibly flawed sample spiking. Welsh, et al., (1993) conducted two exercises with "hair from suspected drug users" and "drug-free hair". In the first exercise, 8 laboratories were sent 8 powdered samples, and 7 laboratories returned quantitative results. Ninety four per cent correctly identified positives, and all correctly identified negatives. However, "scatter in quantitative results was high" (295). In a second exercise, ten laboratories were sent eight hair segments rather than powder. The qualitative results were not as good (78 per cent correctly identified positives, 94 per cent correctly identified negatives), and they comment "quantitatively, the results were more scattered for the second exercise when the hair was in form of short segments." (303) Mieczkowski, et al., (1997) report the despatch of cocaine positive hair samples from 141 individuals to two laboratories. The two laboratories used different assay methods (one RIAH, the other GC/MS) and different cut-offs. None of those deemed negative by GC/MS were deemed positive by RIAH, but 16 of those deemed positive by GC/MS were deemed negative by RIAH. Finally, Kintz & Cirimele (1997) sent a hair sample spiked with AP, MDA and MDMA to 16 different laboratories. The laboratories all used GC/MS (but used a variety of washing procedures) and were asked to test for AP, MA, MDA and MDMA. Two laboratories detected MA (with which the samples were not spiked), three failed to detect AP, two failed to detect MDA and three failed to detect MDMA. For the remainder, the scatter in the concordant set was: for AP (13 positive results) 3.3-17.5; for MA (2 positive results) 0.8-1.8; for MDA (14 positive results) 2.5-19.5; and for MDMA (14 positive results) 3.3-100.00. Such interlaboratory testing for MDMA (and related compound) use as has been conducted so far does not inspire confidence, but divergent results may be because of insufficient sample size (Welsh, et al., 1993), different assay methods (Mieczkowski, et al., 1997), different washing procedures (Kintz & Cirimele, 1997), and/or because the amphetamines are notoriously volatile in the testing process itself (Sachs, 1997a). Clearly, if the first can be boosted, the middle two standardised, and the latter overcome, Surveillance & Society 1(1) Ditton: Hair Testing then an appropriate level of faith in hair analysis might be calibrated. Until then, to reply
to Strang, et al., (1993), hair analysis seems to be more "ethical quagmire" than
"technological breakthrough".
Arnold, W. and K Puschel, (1981) Experimental studies on hair as an indicator of past or
present drug use. Journal of Forensic Science. 21: 83. Baer, J., W. Baumgartner, V. Hill and W. Blahd, (1991) Hair analysis for the detection of drugs use in pretrial, probation and parole populations. Federal Probation, 55: 3-10. Bailey, D. (1989) Drug screening in an unconventional matrix: Hair analysis. Journal of the American Medical Association, 262(23): 3331. Baumgartner, A., P. Jones, W. Baumgartner, and T. Black (1978) Radioimmunoassay of Hair for Determining Opiate-Abuse Histories. Journal of Nuclear Medicine, 20(7): 748-52. Baumgartner, A., P. Jones, and C. Black (1981) Detection of phencyclidine in hair. Journal of Forensic Sciences, 26(3): 576-81. Baumgartner, W., C. Black, P. Jones, and W. Blahd (1982) Radioimmunoassay of cocaine in hair. Journal of Nuclear Medicine, 23: 790-2. Baumgartner, W., V. Hill, and W. Blahd (1989) Hair analysis for drugs of abuse. Journal of Forensic Sciences, 34(6): 1433-1453. Baumgartner, W. and V. Hill, (1996) Hair Analysis for Organic Analytes: Methodology, Reliability Issues, and Field Studies. In P. Kintz (ed.) Drug Testing in Hair. New York: CRC Press, 223-265 Blank, D. and D. Kidwell, (1993) External contaminatio n of hair by drugs of abuse: an issue in forensic interpretation. Forensic Science International, 63: 145-56. Cirimele, V., P. Kintz, and P. Mangin (1995) Detection of amphetamines in fingernails: an alternative to hair analysis. Archives of Toxicology, 70: 68-9. Cirimele, V. (1996) Cannabis and Amphetamine Determination in Human Hair. In P. Kintz (ed.) Drug Testing in Hair. New York: CRC Press, 181-9 Cone, E. and J. Mitchell, (1989) Validity testing of commercial urine cocaine metabolite assays: II. Sensitivity, specificity, accuracy, and confirmation by Gas Surveillance & Society 1(1) Ditton: Hair Testing Chromotography / Mass Spectrometry. Journal of Forensic Sciences, 34(4): 32-45. Cone, E. (1990) Testing human hair for drugs of abuse. I. Individual dose and time profiles of morphine and codeine in plasma, saliva, urine and beard compared to drug induced effects on pupils and behaviour. Journal of Analytic Toxicology, 14: 1-7. Cone, E., D. Yousenejad, W. Darwin and T. Maguire (1991) Testing human hair for drugs of abuse. II. Identification of Unique Cocaine Metabolites in Hair of Drug Abusers and Evaluation of Decontamination Procedures. Journal of Analytic Toxicology, 15: 250-55. Cone, E. and R. Joseph, (1996) The Potential for Bias in Hair Testing for Drugs of Abuse. In P. Kintz (ed.) Drug Testing in Hair. New York: CRC Press, 69-93. Cone, E. (1996) Mechanisms of drug incorporation into hair. Therapeutic Drug Monitoring, 18: 438-443. Cooper, G., D. Allen, K. Scott, J. Oliver, J. Ditton and I. Smith (2000) Hair analysis: Self-reported use of "speed" and "ecstasy" compared with laboratory findings. Journal of Forensic Sciences, 45(2): 400-406. Ditton, J., G. Cooper, K. Scott, D. Allen, J. Oliver and I. Smith (2000) Hair testing for "ecstasy" (MDMA) in volunteer Scottish drug users. Addiction Biology, 5(2): 207-213. Eliopoulos, C., J. Klein and G. Koren (1996) Validation of self- reported smoking by analysis of hair for nicotine and cotinine. Therapeutic Drug Monitoring, 18: 532-6. Fendrich, M., M. Mackesy-Amiti, J. Wislar and P. Goldstein (1997) The reliability and consistency of drug reporting in ethnographic samples. In L. Harrison and A. Hughes (eds.) The validity of self-reported drug use: improving the accuracy of survey estimates. NIDA Research Mono graph 167, Rockville MD, 81-107 Garside, D. and B. Goldberger (1996) Determination of Cocaine and Opiods in Hair. In P. Kintz (ed.) Drug Testing in Hair. New York: CRC Press, 151-180. Goldberger, B., Y. Caplan, T. Maguire and E. Cone (1991) Testing human hair for drugs of abuse. III. Identification of Heroin and 6-Acetylmorphine as Indicators of Heroin Use. Journal of Analytic Toxicology, 15: 226-32. Graham, K., G. Koren, J. Klein, J. Schneiderman and M. Greenwald (1989) Determination of Gestational cocaine exposure by hair analysis. Journal of the American Medical Association, 262(23): 3328-30. Surveillance & Society 1(1) Ditton: Hair Testing Hambridge, K. (1982) Hair analysis: worthless for vitamins, limited for minerals. American Journal of Clinical Nutrition, 36: 943-48. Hammersley, R. (1994) A digest of memory phenomena for addiction research. Addiction, 89(3): 283-94. Harkey, M. and G. Henderson (1989) Hair analysis for drugs of abuse. in: Baselt, R. (ed.) Advances in Analytic Toxicology. Chicago : Year Book Medical Publishers, 298-329 Harkey, M., G. Henderson and C. Zhou (1991) Simultaneous Quantitation of Cocaine and Its Major Metabolites in Human Hair by Gas Chromotography / Chemical Ionization Mass Spectrometry. Journal of Analytic Toxicology, 15: 260-66. Harkey, M. (1993) Anatomy and physiology of hair. Forensic Science International, 63: Harrison, L. and A. Hughes (1997) The validity of self-reported drug use: improving the accuracy of survey estimates., in L. Harrison and A. Hughes (eds.) The validity of self-reported drug use: improving the accuracy of survey estimates. NIDA Research Monograph 167, Rockville MD,1-16. Harrison, W., R. Gray and L. Solomon (1974) Incorporation of D-Amphetamine into Pigmented Guinea Pig Hair. British Journal of Dermatology, 91(4): 415-18. Hossain, M. and B. Johnson (1994) Sweat patches: the potential of a new drug testing technique. Paper presented to the American Society for Criminology Annual Meeting, Miami. Huestis, M. (1996) Technical and Legal Aspects of Drugs of Abuse Testing in Hair. In P. Kintz (ed.) Drug Testing in Hair. New York: CRC Press, 5-15. Huestis, M. (1996a) Judicial acceptance of hair tests for substances of abuse in the United States courts: scientific, forensic and ethical aspects. Therapeutic Drug Monitoring, 84: 456-9. Ishiyama, I., T. Nagai and S. Toshida (1983) Detection of basic drugs (methamphetamine, antidepressants, and nicotine) from human hair. Journal of Forensic Sciences, 28(2): 380-5. Jurado, C., P. Kintz. M. Menendez and M. Repetto (1997) Influence of the cosmetic treatment of hair on drug testing. International Journal of Legal Medicine, 110: 159-163. Surveillance & Society 1(1) Ditton: Hair Testing Kauert, G. and J. Röhrich (1996) Concentrations of ∆9-tetrahydrocannabinol, cocaine and 6-monoacetylmo rphine in hair of drug abusers. International Journal of Legal Medicine, 108: 294-299. Kidwell, D. and D. Blank (1993) Comments on the Paper by W. A. Baumgartne r and V. A. Hill: sample preparation techniques. Forensic Science International, 63: 137-143. Kidwell, D. and D. Blank (1996) Environmental Exposure - the Stumbling Block of Hair Testing. In P. Kintz (ed.) Drug Testing in Hair. New York: CRC Press, 17-68. Kikura, R., K. Takahashi and Y. Nakahara (1994) Detection of Methamphetamine in Hair of Newborn Baby involved in Maternal Methamphetamine Abuse during pregnancy. Journal of Forensic Toxicology, 12: 160-1. Kikura, R. and Y. Nakahara (1995) Hair Analysis for Drugs of Abuse. XI. Disposition of Benzphetamine and its metabolites into Hair and Comparison of Benzphetamine Use and Methamphetamine Use by Hair Analysis. Biology and Pharmacology Bulletin, 18(12): 1694-1699. Kikura, R., Y. Nakahara, T. Mieczkowski and F. Tagliaro (1997) Hair Analysis for Drug Abuse. XV. Disposition of 3,4- methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse. Forensic Science International, 84: 165-177. Kintz, P., B. Ludes and P. Mangin (1992) Detection of drugs in human hair using Abbott ADx, with confirmation by gas chromotography / mass spectrometry (GC/MS). Journal of Forensic Science, 37: 328-31. Kintz, P. and V. Cirimele (1997) Interlaboratory comparison of quantitative determination of amphetamine and related compounds in hair samples. Forensic Science International, 84: 151-156. Lewis, D., C. Moore, P. Morrissey and J. Leikin (1997) Determination of drug exposure using hair: application to child protection cases. Forensic Science International, 84:123-8. Magura, S. and S-Y. Kang (1996) Validity of self- Reported Drug Use in High Risk Populations: A Meta-analytical Re view. Substance Use and Misuse, 31(19): 1131-1153. Mangin, P. (1996) Drug Analysis in Nonhead Hair. In P. Kintz (ed.) Drug Testing in Hair. New York: CRC Press, 279-287 Surveillance & Society 1(1) Ditton: Hair Testing Marigo, M., F. Tafliaro, S. Lafisca and C. Neri (1986) Determination of morphine in the hair of heroin addicts by high performance liquid chromotography with fluorimetric detection. Journal of Analytic Toxicology, 10: 158-161. Marques, P., A. Tippetts and D. Branch, (1993) Cocaine in the Hair of Mother-Infant Pairs: Quantitative Analysis and Correlations with Urine Measures and Self-Report. American Journal of Drug and Alcohol Abuse, 19(2):159-75. Marques, P. (1993) Hair testing for Maternal or Infant Cocaine Exposure. Paper presented to NIDA Alliance Conference. Marques, P., A. Tippetts and D. Branch (1994) Birth outcome not correlated with late- term cocaine exposure within an exposed sample. Paper presented to CPDD Meeting, Palm Beach. Matsuno, H., T. Uematsu and M. Nakashima (1990) The measurement of haloperidol and reduced haloperidol in hair as an index of dosage history. British Journal of Clinical Pharmacology, 29: 187-94. Mieczkowski, T., D. Barzeley, B. Gropper and E. Wish (1991) Concordance of Three Measures of Cocaine Use in an Arrestee Popula tion: Hair, Urine, and Self-report. Journal of Psychoactive Drugs, 23(3): 241-9. Mieczkowski, T. (1992) Immunochemical Hair Assays, Urinalysis, Self- Reported Use and the Measurement of Arrestee Cocaine and Marihuana Exposure. Paper for the First International Meeting on Hair Analysis as a Diagnostic Tool for Drugs of Abuse Investigation, Genoa, Italy. Mieczkowski, T. (1992a) An Evaluation of Patterns of Racial Bias in Hair Assays for Cocaine: Black and White Arrestees Compared. Paper for the First International Meeting on Hair Analysis as a Diagnostic Tool for Drugs of Abuse Investigation, Genoa, Italy. Mieczkowski, T. (1992b) New Approaches in Drug Testing: A Review of Hair Analysis. Annals, AAPSS, 521:132-50. Mieczkowski, T. and R. Newel (1994) Patterns of concordance between hair assays and urinalysis for cocaine: longitudinal analysis of probationers in Pinellus County, Florida. Paper presented to the American Society for Criminology Annual Meeting, Miami. Mieczkowski, T. (1996) The use of hair analysis for the detection of drugs: an overview. Journal of Clinical Forensic Medicine, 3: 59-71. Surveillance & Society 1(1) Ditton: Hair Testing Mieczkowski, T., R. Mumm and H. Connick (1997) A research note: an analysis of RIA and GC/MS split hair samples from the New Orleans pretrial diversion program. Forensic Science International, 84: 67-73. Moeller, M. (1992) Drug detection in hair by chromatographic procedures. Journal of Chromatography, 580:125-134. Moeller, M., H. Maurer and M. Roesler (1992) MDMA in blood, urine and hair: a forensic case. In T. Nagata (ed.) Proceedings, 30th TIAAFT Meeting. Fukouka, Japan: Yoyodo Printing Kaisha Ltd, 56-61 Moeller, M., P. Fey and H. Sachs (1993) Hair analysis as evidence in forensic cases. Forensic Science International, 63: 43-53. Moeller, M. (1996) Hair analysis as evidence in forensic cases. Therapeutic Drug Monitoring, 18 444-9. Nagai, T., M. Sato, T. Nagai, S. Kamiyama and Y. Miura (1989) A new analytical method for stereoisomers of methamphetamine and amphetamine and its application to forensic toxicology. Clinical Biochemistry, 22: 439-42. Nakahara, Y., K. Takahashi, M. Shimamine and Y. Takeda (1991) Hair Analysis for Drug Abuse: 1. Determination of Methamphetamine and Amphetamine in Hair by Stable Isotope Dilution Gas Chromotography / Mass Spectrometry Method. Journal of Forensic Sciences, 36(1): 70-78. Nakahara, Y., K. Takshashi, Y. Takeda, K. Kunoma, S. Kukui and T. Tokui (1990) Hair analysis for drug abuse. Part II. Hair analysis for monitoring of methamphetamine abuse by stable isotope dilution gas chromotography / mass spectrometry. Forensic Science International, 46: 243-54. Nakahara, Y., M. Shimamine and K. Takahashi (1992) Hair analysis for drugs of abuse. III. Movement and stability of methoxzyphenamine (as a model compound of methamphetamine) along hair shaft with hair growth. Journal of Analytic Toxicology, 16: 253-7. Nakahara, Y., K. Takahashi, and K. Konuma, (1993) Hair analysis for Drugs of Abuse. VI. The excretion of methoxyphenamine and methamphetamine into beards of human subjects. Forensic Science International, 63:109-119. Nakahara, Y., R. Kikura, T. Sakamoto, T. Mieczkowski, F. Tabliaro and R. Foltz (1995) Findings in hair analysis for some hallucinogens (LSD, MDA/MDMA and PCP). Proceedings of the Abu Dhabi Hair Analysis Conference, 161-184. Nakahara, Y. (1995) Detection and diagnostic interpretation of amphetamines in hair. Forensic Science International, 70:135-153. Surveillance & Society 1(1) Ditton: Hair Testing Nakahara, Y. and R. Kikura (1996) Hair analysis for Drugs of Abuse. XIII. Effect of structural factors on incorporation of drugs into hair: the incorporation rates of amphetamine analogs. Archives of Toxicology, 70: 841-849. Nakahara, Y., R. Kikura, M. Yasuhara and T. Mukai (1997) Hair analysis for Drugs of Abuse. XIV. Identification of substances causing acute poisoning using hair root. I. Methamphetamine. Forensic Science International, 84:157-164. Nakahara, Y. and R. Kikura (1997) Hair Analysis for Drugs of Abuse. XVIII. 3,4- Methylenedioxymethamphetamine (MDMA) Disposition in Hair Roots and Use in Identification of Acute MDMA Poisoning. Biology and Pharmacology Bulletin, 20(9): 969-972. Pépin, G. and Y. Gaillard (1997) Concordance between self-reported drug use and findings in hair about cocaine and heroin. Forensic Science International, 84: 37-41. Pötsch, L. and M.R. Moeller (1996) On Pathways for Small Molecules Into and Out of Human Hair Fibres. Journal of Forensic Sciences, 41(1): 121-125. Röhrich, J. and G. Kauert (1997) Determination of amphetamine and methylenedioxy- amphetamine-derivatives in hair. Forensic Science International, 84: 179-188. Rothe, M., F. Pragst, K. Spiegel, T. Harrach, K. Fischer and J. Kunkel (1997) Hair concentrations and self- reported abuse history of 20 amphetamine and ecstasy users. Forensic Science International, 89:111-128. Sachs, H. (1997) History of Hair Analysis. Forensic Science International, 84: 7-16. Sachs, H. (1997a) Quality control by the Society of Hair Testing. Forensic Science International, 84: 145-50. Sakamoto, T. and A. Tanaka (1996) Hair analysis for Drugs of Abuse. XII. Determination of PCP and Its Major Metabolites, PCHP and PPC, in Rat Hair after administration of PCP. Journal of Analytic Toxicology, 20(March/April): 124-120. Skopp, G., L. Potsch and M. Moeller (1997) On cosmetically treated hair - aspects and pitfalls of interpretation. Forensic Science International, 84:43-52. Smith, F. and D. Pomposine (1981) Detection of phenobarbital in bloodstains, semen, seminal stains, saliva, saliva stains, and hair. Journal of Forensic Science, 26: 582-6. Surveillance & Society 1(1) Ditton: Hair Testing Sramek, J., W. Baumbartner, T. Ahrens, V. Hill and N. Cutler (1992) Detection of benzodiazepines in human hair by radioimmunoassay. The Annals of Pharmacotherapy, 26: 469-72. Strang, J., J. Black, A. Marsh and B. Smith (1993) Editorial. Hair analysis for drugs: technological breakthrough or ethical quagmire? Addiction, 88: 163-66. Suzuki, O., H. Hattori and M. Asano (1984) Detection of Amphetamine and Meth- Amphetamine in a Single Human Hair by Gas Chromatography / Chemical Ionization Mass Spectrometry. Journal of Forensic Sciences, 29: 611-617. Suzuki, O., H. Hattori and M. Asano (1984a) Nails as useful materials for detection of methamphetamine or amphetamine abuse. Forensic Science International, 24: 9-16. Tagliaro, F., Z. De Battisti, G. Lubli, C. Neeri, G. Manetto and M. Marigo (1997) Integrated use of hair analysis to investigate the physical fitness to obtain the driving licence: a casework study. Forensic Science International, 84: 129-35. Takayama, N., S. Tanaka and K. Hayakawa (1997) Determination of stimulants in a Single Human Hair Sample by High-Performance Liquid Chromatographic Method with Chemiluminescence Detection. Biomedical Chromatography, 11: 25-28. Welsh, M., L. Sniegoski and C. Allgood (1993) Interlaboratory comparison studies on the analysis of hair for drugs of abuse. Forensic Science International, 63: 295-303. Wish, E., J. Hoffman and S. Nemes (1997) The validity of self-reports of drug use at treatment admission and at followup: comparisons with urinalysis and hair assays. In L. Harrison and A. Hughes (eds.) The validity of self-reported drug use: improving the accuracy of survey estimates. NIDA Research Monograph 167, Rockville MD, 200-226 Surveillance & Society 1(1)


Bm-livret ast-gb.indd

TB, Etest, Myla, VITEK are used, pending and/or registered the blue logo, Empowering Clinical Decisions, API, A / RCS Lyon B 398 160 242. The information in this booklet is given as a guideline only and is not intended to be exhaustive. It in no way binds bioMérieux S.A. to the diagnosis established or the treatment prescribed by the physician. bioMérieux S.A.

March 2010 center view.indd

Tucson Jewish Community Center Your Connection For Information VOLUME 16 • NUMBER 2 MARCH 2010 • ADAR/NISAN 5770 SUMMER CAMP 2010 The Tucson JCC Jewish Author Series proudly presents Oasis in the Desert! Carol Leifer & Get ready for another spectacular